Chasidy buys PRIM 27.76: Five Prime Therapeutics Announces Second Quarter 2014 Financial Results
SOUTH SAN FRANCISCO, Calif., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory ... ...
55 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home